banner ad
banner ad

jeff

rss feed

Exclusive interview: Rep. Paul Ryan discusses need for ‘market-based’ health reform

September 4, 2012 |

Wisconsin Rep. Paul Ryan’s selection as the Republican vice presidential nominee  has put Medicare reform back in the national spotlight, as Ryan’s plans for  transforming Medicare into a “premium support” system gain renewed  attention. Of particular significance is how Ryan’s  plan to offer beneficiaries federal payments to pick the health plan of  their choice goes […]

Read More

Will starving yourself help you live longer? Maybe not

August 30, 2012 |

The longevity diet’s premise is seductively simple: cutting your calorie intake well below your usual diet will add years to your life. New research published on Wednesday, however, shows the extreme, emaciating diet doesn’t increase lifespan in rhesus monkeys, the closest human relatives to try it in a rigorous, long-running study. While caveats remain, outside […]

Read More

Lasers: the hot, new anti-aging technique (stress the ‘hot’)

August 27, 2012 |

When 35-year-old Francesca Zielinski stepped out of her dermatologist’s office after her first Erbium laser treatment, her face felt “really hot – like a bad sunburn.” The Toronto-based receptionist raced home and spent the next several hours applying washcloths soaked in ice water to bring down the heat. But the next day was even worse. […]

Read More

Summer Is the Best Time for Injectable Treatments

August 20, 2012 |

Summer is the ideal time to rejuvenate the face with injectable treatments, as little to no recovery time is needed. Injectable treatments are ideal facial rejuvenation therapies for the busy summer social season, says plastic surgeon Dr. Scott Zevon. Nonsurgical therapies with little downtime, injectables offer an alternative to the long recovery time associated with […]

Read More

Study: Nearly half drop out of weight-loss programs

August 2, 2012 |

Nearly half of participants in weight-loss programs drop out before  completing them, according to a new study. The researchers found that 43 percent of participants in one weight-loss  program — including some who underwent bariatric surgery — dropped out of the program before  dropping the desired pounds. Among participants who had undergone the surgery, the […]

Read More

New drug makes Botox effects last longer

July 25, 2012 |

An accidental medical discovery can make the effects of Botox last 30 percent longer, according to a Houston doctor. Many people know Botox as a beauty enhancer that erases age lines and leaves the skin looking smooth and youthful. But for thousands of people, it is a sanity saving treatment for very real medical conditions. […]

Read More

FDA Approves Diet Drug Qsymia

July 23, 2012 |

For the second time in less than a month, the FDA has approved a new prescription weight loss drug. Qsymia, developed by California-based Vivus Inc., combines two already prescribed medications — the stimulant phentermine and the anti-seizure drug Topamax (topiramate) — in a controlled-release pill that is taken once a day. Last February, an FDA […]

Read More

Botox may help multiple sclerosis tremors

July 5, 2012 |

Botox injections may provide some relief from arm tremors caused by multiple sclerosis, according to a small study published Monday. Botulinum toxin type A is sold under different brands, but it’s best known by the Allergan brand-name Botox. Botox gained fame for smoothing aging skin — by blocking nerve signals and relaxing muscles under the […]

Read More

Wellness Centers and Liability

June 28, 2012 |

CAN I MAKE A PROFIT FROM THIS?” “What liabilities are involved?” These two questions are guaranteed to come up in regards to any emerging industry. As one of the fastest growing new industries on the market today, the business of wellness is no exception. Ten years ago, medical spas were the emerging trend. In today’s […]

Read More

Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese

June 28, 2012 |

First Prescription Weight-Loss Treatment Approved by FDA in 13 Years Eisai to Launch BELVIQ in U.S. Following DEA’s Completion of Scheduling Review Arena Pharmaceuticals, Inc.(NASDAQ: ARNA) andEisai Inc.announced today that theU.S. Food and Drug Administration(FDA) has approved BELVIQ (pronounced BEL-VEEK) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management […]

Read More

banner ad
banner ad